Abstract
The effect of F-18-fluorodeoxyglucose positron emission tomography imaging on decision making in the selection of patients with impaired ventricular function for revascularization was determined in 87 patients. In 57% of patients, positron emission tomography data influenced management decisions, indicating an important effect of myocardial viability determination on difficult therapy decisions in these patients.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Coronary Disease / complications
-
Coronary Disease / diagnostic imaging
-
Coronary Disease / metabolism
-
Coronary Disease / surgery*
-
Decision Making*
-
Deoxyglucose / analogs & derivatives*
-
Female
-
Fluorine Radioisotopes*
-
Fluorodeoxyglucose F18
-
Humans
-
Male
-
Middle Aged
-
Myocardial Revascularization
-
Myocardium / metabolism*
-
Prospective Studies
-
Tomography, Emission-Computed* / methods
-
Ventricular Dysfunction, Left / diagnostic imaging*
-
Ventricular Dysfunction, Left / etiology
-
Ventricular Dysfunction, Left / metabolism
-
Ventricular Dysfunction, Left / surgery
Substances
-
Fluorine Radioisotopes
-
Fluorodeoxyglucose F18
-
Deoxyglucose